General Medicines
Wo Ideen und Wissenschaft die Gesundheit von morgen gestalten.

Job title: Real World Evidence Scientific Lead

• Location: Morristown, NJ, Cambridge, MA

About the Job

We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes andtransplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation indiabetes and transplant medicines, we pursue Progress to make a real impact on millions of patients around the world

The Real-World Data & Evidence Science (RWD&ES) team, in General Medicines Medical, serves as an end-to-end strategy and execution partner to solve business problems using real-world data. We partner with cross functional partners to lead end-to-end the planning and execution of real-world evidence (RWE) strategies.

Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions.

About Sanofi

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

Main responsibilities:

The Real-World Evidence (RWE) Scientific Lead is an essential scientific position responsible for managing the implementation of cutting-edge, effective, and efficient real world evidence strategy for the development of autoimmune type 1 diabetes (aT1D).

As such, you are responsible for the end-to-end high-quality execution of real-world studies, working in close partnership with the global RWE Strategy aT1D Lead and internal and external cross functional collaborators.

Your main responsibilities are as follows:

• Partner with the Real-World Evidence Strategy AT1D Lead to deliver the value of RWE for the registration, pre-launch and peri-launch of teplizumab in autoimmune type 1 diabetes.

• Manage the end-to-end planning, execution and communication of specific research studies, ensuring that deliverables areon time, within budget, to specification and of high scientific rigor that demonstrates commitment to quality.

• Deliver strategic scientific input in all stages of RWE study conceptualization through study closure, including study design,cohort construction, protocol & statistical analysis plan development, study operations, data analysis, results interpretation and clinical study report development.

• Collaborate with cross-functional stakeholders and relevant internal and external scientific experts based on specific needs of individual RWE studies to ensure that the real-world data and RWE generation is fit-for-purpose to the intended use, whether for regulatory, market access or clinical use.

• Serve as methodological expert in the design and execution of real-world study plans to address critical evidence generation gaps as well as in-house study methodology expert leveraging opportunities to use innovative RWE study designs and analytics to deliver on critical needs.

• Identify and validate external fit-for-purpose data sources, associated institutions and/or organizations, in collaboration with other members of the RWD&ES team.

• Manage the development of budgets for RWE studies in collaboration with relevant internal and externalstakeholders, including RWE Operations, Sanofi Global Hub and/or vendors as appropriate, to support the annual strategic and budget planning process and periodic updates.

• Maintain timely communication and close alignment with team members, partners and stakeholders to ensure clearand timely visibility the evidence strategy, study progress and anticipation of challenges and risk mitigation.

• Accountable for supporting GenMed medical gaps within the Global Integrated Evidence Generation Plans (IEGP).

About You

You are a self-starter who brings your energy, expertise and experience as well as takes an entrepreneurial approach to solving problems, have a growth mindset and are passionate about unleashing the power of real-world data with data science to improve health.

• Advanced degree in pharmaco-epidemiology, biostatistics, or Health Outcomes (PhD preferred). Education in business is a plus.

• Minimum 5 years in real-world evidence (RWE) generation for pharmaceutical industry with end to end leadership experience

• Strong publication track record in relevant journals.

• Experience across therapeutic areas, including transplant, diabetes, and cardiovascular.

Soft Skills:

• Ability to influence and motivate teams as well as senior leaders.

• Strategic thinking for innovative evidence generation.

• Urgency, ownership, and proactive attitude.

Technical Skills:

• Expertise in pharmacoepidemiology, HEOR, and RWE study design.

• Working with routinely collected healthcare data.

• End-to-end project management for real-world studies.

• Understanding of commercial strategy.

• Fluent English is mandatory, a second European language is appreciated.

Why Choose Us

• Bring the miracles of science to life alongside a supportive, future-focused team.

• Discover endless opportunities to grow your talent and drive your career, whether it’s through a promotion or lateral move, at home or internationally.

• Enjoy a thoughtful, well-crafted rewards package that recognizes your contribution and amplifies your impact.

• Take good care of yourself and your family, with a wide range of health and wellbeing benefits including high-quality healthcare, prevention and wellness programs and at least 14 weeks’ gender-neutral parental leave.

• Be part of a pioneering biopharma company that engages patients early in drug development and uses their insights to design studies that reflect real-world needs.

• Help improve the lives of millions of people globally by making drug development quicker and more effective.

• Work at the forefront of drug discovery, harnessing cutting-edge AI, data, and digital platforms to push the boundaries of science.

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#GD-SA
#LI-SA
#vhd

#LI-Hybrid

All compensation will be determined commensurate with demonstrated experience. Employees may be eligible to participate in Company employee benefit programs, and additional benefits information can be found here.

Pursue Progress. Discovery Extraordinary.

Werde Teil von Sanofi und starte mit uns in eine neue Ära der Wissenschaft – wo dein persönliches Wachstum genauso wegweisend ist wie unsere Arbeit. Wir investieren in dich, damit du weiterkommst, schneller denkst und Dinge möglich machst, die vorher undenkbar waren. Du wirst Grenzen verschieben, Gewohntes hinterfragen und smarte Lösungen entwickeln, die direkt bei den Menschen ankommen, für die wir da sind. Bereit, die Wunder der Wissenschaft zu jagen und Leben zu verbessern? Dann lass uns gemeinsam Großes bewegen – und das Außergewöhnliche entdecken.

Bei Sanofi stehen allen die gleichen Chancen offen – unabhängig von Herkunft, Hautfarbe, Religion, Geschlecht, Nationalität, sexueller Orientierung, Alter, Staatsangehörigkeit, Familienstand, Behinderung, Geschlechtsidentität, Veteranenstatus oder anderen gesetzlich geschützten Merkmalen.